Literature DB >> 14739109

The promise of lentiviral gene therapy for liver cancer.

Antonia Follenzi, Sanjeev Gupta.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 14739109     DOI： 10.1016/j.jhep.2003.11.023

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  6 in total

1.  CPNE1 silencing inhibits the proliferation, invasion and migration of human osteosarcoma cells.

Authors:  Zhenhuan Jiang; Jiannong Jiang; Bizeng Zhao; Huilin Yang; Yunliang Wang; Shang Guo; Youping Deng; Deyi Lu; Tieliang Ma; Hongwei Wang; Jinzhi Wang
Journal:  Oncol Rep       Date:  2017-12-04       Impact factor: 3.906

2.  A potential targeting gene vector based on biotinylated polyethyleneimine/avidin bioconjugates.

Authors:  Xuan Zeng; Yun-Xia Sun; Xian-Zheng Zhang; Si-Xue Cheng; Ren-Xi Zhuo
Journal:  Pharm Res       Date:  2009-06-05       Impact factor: 4.200

3.  A diphtheria toxin resistance marker for in vitro and in vivo selection of stably transduced human cells.

Authors:  Gabriele Picco; Consalvo Petti; Livio Trusolino; Andrea Bertotti; Enzo Medico
Journal:  Sci Rep       Date:  2015-09-30       Impact factor: 4.379

4.  Lentivirus mediated silencing of ubiquitin specific peptidase 39 inhibits cell proliferation of human hepatocellular carcinoma cells in vitro.

Authors:  Zeya Pan; Hao Pan; Jin Zhang; Yun Yang; Hui Liu; Yuan Yang; Gang Huang; Junsheng Ni; Jian Huang; Weiping Zhou
Journal:  Biol Res       Date:  2015-03-19       Impact factor: 5.612

5.  Alarmin augments the antitumor immunity of lentiviral vaccine in ectopic, orthotopic and autochthonous hepatocellular carcinoma mice.

Authors:  Zhili Liu; Zhen Lu; Renwei Jing; Bingfeng Zuo; Xianjun Gao; Gang Han; Han Qi; Li Wu; Yunde Liu; Haifang Yin
Journal:  Theranostics       Date:  2019-05-31       Impact factor: 11.556

6.  Effective Amelioration of Liver Fibrosis Through Lentiviral Vector Carrying Toxoplasma gondii gra15II in Murine Model.

Authors:  Lei Liu; Mengmeng Jin; Qing Tao; Li Yu; Jian Du; Cong Wang; Qingli Luo; Tian Xing; Yuanhong Xu; Jilong Shen; Deyong Chu
Journal:  Front Immunol       Date:  2018-07-06       Impact factor: 7.561
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.